Crescent NV Stock Quote OPTI - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
Europe
EU
Crescent NV (OPTI) Quote

Crescent NV (OPTI)

0.0118

0.0004

(3.51%)

Closed October 05 11:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.0118

Bid

0.0112

Ask

0.0118

Volume

1,529,837

0.011 Day's Range 0.012

0.006 52 Week Range 0.0146

Market Cap

Previous Close

0.0114

Open

0.0114

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

482,938

Shares Outstanding

1,994,069,000

Dividend Yield

-

PE Ratio

-2.86

Earnings Per Share (EPS)

-0

Revenue

17.1M

Net Profit

-7.01M

Sector

Communications Services, Nec

Industry

Communications Services, Nec

Website

www.crescent-ventures.com

Headquarters

Leuven, Flemish Brabant, Bel

Founded

-

Crescent NV is listed in the Communications Services sector of the Euronext with ticker OPTI. The last closing price for Crescent NV was 0.01 €. Over the last year, Crescent NV shares have traded in a share price range of 0.006 € to 0.0146 €.

Crescent NV currently has 1,994,069,000 shares outstanding. The market capitalization of Crescent NV is 22.73 € million. Crescent NV has a price to earnings ratio (PE ratio) of -2.86.

VASCO Data Security and Option Launch Cloudkey, a DIGIPASS With 3G Connectivity and User-Friendly Software

VASCO Data Security and Option Launch Cloudkey, a DIGIPASS With 3G Connectivity and User-Friendly Software Cloudkey® offers secure access to applications and data in the cloud PR...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0002	-1.66666666667	0.012	0.0124	0.011	814362	0.01190137	DE
4	0	0	0.0118	0.0134	0.011	920839	0.01220263	DE
12	0	0	0.0118	0.0134	0.01	482938	0.01212718	DE
26	-0.0006	-4.83870967742	0.0124	0.0146	0.01	649827	0.01275047	DE
52	0.0018	18	0.01	0.0146	0.006	915751	0.010177	DE
156	-0.0167	-58.5964912281	0.0285	0.0289	0.0001	1351369	0.0179624	DE
260	-0.021	-64.0243902439	0.0328	0.0553	0.0001	2360665	0.02926192	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLSMLSmalto	0.018 € (80.00%)	3k
ALACTActicor Biotech	0.469 € (46.56%)	317.71k
MLGEQGentlemen S Equity SA	0.014 € (40.00%)	40
LVIDELavide Holdings NV	0.426 € (35.67%)	281.53k
ALTHOMetavisio (Thomson Computing)	0.394 € (33.56%)	1.64M
ALNSCNsc Groupe	52.50 € (-28.57%)	99
ALICRICeram	0.472 € (-20.00%)	920
CDUConduril Engenharia SA	22.80 € (-18.57%)	200
ALREARealites	3.57 € (-16.98%)	11.32k
LIGLisgrafica	0.005 € (-16.67%)	30.01k
BCPBanco Comercial Portugues SA	0.3975 € (1.64%)	54.71M
ALAVEAventador	0.0022 € (22.22%)	30.83M
ALCYBCybergun	0.0001 € (0.00%)	17.37M
ALNEVNeovacs	0.0005 € (0.00%)	11.46M
ORAOrange.	9.778 € (-0.14%)	10.08M

Arnold25764

Arnold25764 4 minutes ago

Would be nice. See what next week brings.

boston127

boston127 9 minutes ago

Not even Elon Musk could afford

to buy on every dip with this company. It is one nonstop long dip.

Prominent Capital

Prominent Capital 9 minutes ago

This might be huge:

AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Source: GlobeNewswire Inc.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Pat

Dallas-Cowboys

Dallas-Cowboys 10 minutes ago

Good for Nvidia

Data center finance leases
Buried within the footnote of its quarterly and annual reports, Microsoft lists the number of finance leases, mostly for data centers, that have yet to commence. The details include the amount of money it has contracted out for leases

boston127

boston127 12 minutes ago

I'm hoping that you are correct.

- Has the company even applied for it?
- Why is the company so dull and not enthusiastically touting their accomplishments?
- Their website sucks and is outdated by a few years.
- We do not hear a word from them on anyth

bbotcs

bbotcs 17 minutes ago

lj: Florida weather
Thanks for the weather forecast video. A neighbor just cancelled her planned trip to Florida next week to visit her elderly mother.

bbotcs

bbotcs 21 minutes ago

lj: re: interest rates
I think we are in a mild recession. When you don't see many cars at fast-food drive throughs, something is going on.
Egg prices are ridiculous. Eggs are in many food products. IMO, a big part of food inflation.

fuagf

fuagf 24 minutes ago

In Mexico, ‘It’s Time for Women’

"Who is Claudia Sheinbaum? Here’s what to know about Mexico’s next president"

Claudia Sheinbaum took office on Tuesday as the country’s first female president.

By Catherine Osborn, the writer of Foreign Policy’s weekly Lat

bbotcs

bbotcs 25 minutes ago

lj: Agree about the tax-loss selling this year. Not much out there to push up the market.
The election is a factor that should keep the market down for a month.

shajandr

shajandr 27 minutes ago

https://www.gq.com/story/californias-vanishing-hippie-utopias

Horsts

Horsts 28 minutes ago

😂😂😂😂🤡

Hopeforthefuture3

Hopeforthefuture3 29 minutes ago

If merck want nwbo they still have time to make a purchase. They (MRK)may not think the market for gbm (dcvax plus keytruda) is large enough for them in terms of revenue especially until approved by fda. Should we get approval by MHRA merck may take an interest as then better chance for fda/usa appr

Horsts

Horsts 31 minutes ago

Cool.
Does Shaun the Sheep and Epaz know this ?
Do they have that information ?

WesCrowe

WesCrowe 36 minutes ago

Whats a reasonable Market Cap for 4 million in revenue. No debt. 9-10 million next year. Patents and no reverse split. &dvm traded up too 21,000 million with less revenue or similiar. I feel anywhere between 9-24 million is a reasonable area and range for Sinc.

Nrdc92

Nrdc92 42 minutes ago

There you go spinning nonsense again, Proto. Stephano Slack is a rinky-dink regional firm, wholly inappropriate for an alleged soon to be ubiquitous Nasdaq tech company. This proves again that LWLG is still playing in the minors, hoping one day to make it to the big leagues.

This is

pepeoil

pepeoil 46 minutes ago

The cult page wants an update from the receiver. If he did give one, it would be real simple. “Boys, you’re screwed”. Lol. Some clowns from the cult actually think the receiver is going to move the company forward. lol. Little do they know, he is unwinding it.

toogoodfella

toogoodfella 55 minutes ago

Re: still incoming from lawsuits?

Also, it says there will be a small group of administrator staff to remain and manage other litigations.

I EXPLAINED IT MANY TIMES

Check the cash flow. 210M is the only asset left to distribute. Ecaps money not included.

AngeloFoca

AngeloFoca 56 minutes ago

Merck could be sitting alone wondering what could have been.
It's exactly what I've been thinking... While we are all focused on Merck, it may well be someone we haven't even considered.

.

Mr.Poole

Mr.Poole 1 hour ago

ILUS leadership can’t merge into traffic much less merge companies. Heck can’t even change their name for how many years now. Got to hand it to them with dogged determination to the grift.

toogoodfella

toogoodfella 1 hour ago

RE: still incoming from lawsuits?

Nothing is coming other than ecaps money. Read the quarterly report. It says money from ecaps not included in the recovery.

Mr.Poole

Mr.Poole 1 hour ago

Shadyland scam just like BRYYF. His comical chart posts with that fictitious upward spike that never comes,

fuagf

fuagf 1 hour ago

Very nice. How did i miss it earlier, and how in hell did i get back
there just now. LOL It's a good view Jacy, of the two of you.

georgejjl

georgejjl 1 hour ago

"...Cognision, providers of advanced neurobiomarker technology, announces its partnership with Anavex Life Sciences Corp. (Nasdaq: AVXL), in a phase 2 clinical trial of ANAVEX®3-71 in subjects with schizophrenia.

ANAVEX®3-71 is a therapeutic agent with a dual mecha

fuagf

fuagf 1 hour ago

Steve Schmidt is always good. "Decency is making a comeback in America" And that's a good thing.

Delayed Upgrade Clock